Tag: Opioids
Screening for Opioid-Related Low Testosterone Underused
Rates of screening, treatment for low testosterone higher for prolonged versus short-term opioid users
Purdue Pharma Tentatively Reaches Settlement in Opioid Lawsuits
Deal is said to be worth $10 billion to $12 billion; company will not admit to wrongdoing
Risk for Long-Term Opioid Use Up in Hidradenitis Suppurativa
Odds higher for HS patients with advancing age, ever smoking, history of depression, comorbidity
Opioid Maker Purdue Pharma Expected to File for Bankruptcy
Settlement talks over Purdue's responsibility for the nation's opioid crisis have stalled
Use of Pain Reliever Tramadol May Up Risk for Hypoglycemia
Retrospective analysis of adverse events reported to FDA shows risk similar to that seen with methadone
White House Announces Nearly $2 Billion in Grants to Fight Opioid Epidemic
SAMHSA will provide $932 million to every state, some U.S. territories for treatment, recovery programs
Cesarean Section Quality Initiative Cuts Opioid Use
Preoperative and postoperative process changes lead to faster recovery without increased pain
CDC: January to July 2018 Saw Decrease in Opioid Deaths
But deaths from illicitly manufactured fentanyl increased during same period
Prenatal Exposure to OMT Does Not Worsen Neonatal Outcomes
Growth parameters similar to those for newborns of women with opioid use disorders during pregnancy
OxyContin Maker Offers Up to $12 Billion to Settle Opioid Claims
Potential deal has been discussed by lawyers representing Purdue and at least 10 state attorneys general
